Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

927.15

-19.95 (-2.11%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences gets USFDA’s final approval for Niacin Extended-Release Tablets

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences surges on the BSE

>>

USFDA concludes surveillance inspection at Zydus group’s API unit in Gujarat

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences’ arm enters into strategic partnership with Braile Biomedica Industria

>>

Zydus Lifesciences informs about press release

>>

Zydus Lifesciences’ venture capital arm invests in Feldan Therapeutics

>>

Zydus Lifesciences’ US division recalls 3,144 bottles of chlorproMAZINE Hydrochloride Tablets

>>

Zydus Lifesciences’ arm incorporates wholly owned subsidiary in France

<< < 14 15 16 ...168 > >>